Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22672 | 317 | 38.3 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | DCR3 | Author keyword | 81 | 87% | 13% | 40 |
| 2 | DECOY RECEPTOR 3 | Author keyword | 38 | 78% | 8% | 25 |
| 3 | TL1A | Author keyword | 29 | 73% | 7% | 22 |
| 4 | VASCULAR ENDOTHELIAL GROWTH INHIBITOR | Author keyword | 13 | 80% | 3% | 8 |
| 5 | DEATH RECEPTOR 3 | Author keyword | 9 | 67% | 3% | 8 |
| 6 | VEGI | Author keyword | 7 | 57% | 3% | 8 |
| 7 | DECOY RECEPTOR 3 DCR3 | Author keyword | 7 | 67% | 2% | 6 |
| 8 | DR3 | Author keyword | 4 | 34% | 3% | 10 |
| 9 | TNFRSF25 | Author keyword | 4 | 75% | 1% | 3 |
| 10 | TNFSF15 | Author keyword | 4 | 36% | 3% | 8 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | DCR3 | 81 | 87% | 13% | 40 | Search DCR3 | Search DCR3 |
| 2 | DECOY RECEPTOR 3 | 38 | 78% | 8% | 25 | Search DECOY+RECEPTOR+3 | Search DECOY+RECEPTOR+3 |
| 3 | TL1A | 29 | 73% | 7% | 22 | Search TL1A | Search TL1A |
| 4 | VASCULAR ENDOTHELIAL GROWTH INHIBITOR | 13 | 80% | 3% | 8 | Search VASCULAR+ENDOTHELIAL+GROWTH+INHIBITOR | Search VASCULAR+ENDOTHELIAL+GROWTH+INHIBITOR |
| 5 | DEATH RECEPTOR 3 | 9 | 67% | 3% | 8 | Search DEATH+RECEPTOR+3 | Search DEATH+RECEPTOR+3 |
| 6 | VEGI | 7 | 57% | 3% | 8 | Search VEGI | Search VEGI |
| 7 | DECOY RECEPTOR 3 DCR3 | 7 | 67% | 2% | 6 | Search DECOY+RECEPTOR+3+DCR3 | Search DECOY+RECEPTOR+3+DCR3 |
| 8 | DR3 | 4 | 34% | 3% | 10 | Search DR3 | Search DR3 |
| 9 | TNFRSF25 | 4 | 75% | 1% | 3 | Search TNFRSF25 | Search TNFRSF25 |
| 10 | TNFSF15 | 4 | 36% | 3% | 8 | Search TNFSF15 | Search TNFSF15 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TNF LIKE LIGAND | 80 | 90% | 11% | 35 |
| 2 | TL1A | 46 | 71% | 12% | 37 |
| 3 | VEGI | 37 | 100% | 4% | 14 |
| 4 | DCR3 | 30 | 84% | 5% | 16 |
| 5 | TR6 DCR3 | 23 | 100% | 3% | 10 |
| 6 | CYTOKINE 1A TL1A | 20 | 100% | 3% | 9 |
| 7 | DR3 | 18 | 49% | 8% | 26 |
| 8 | LIGHT MEDIATED APOPTOSIS | 15 | 73% | 3% | 11 |
| 9 | ENDOTHELIAL GROWTH INHIBITOR | 14 | 100% | 2% | 7 |
| 10 | DECOY RECEPTOR 3 | 13 | 45% | 7% | 22 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation | 2011 | 33 | 47 | 77% |
| Advancement in the research on vascular endothelial growth inhibitor (VEGI) | 2012 | 4 | 20 | 90% |
| The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases | 2015 | 0 | 75 | 88% |
| The Role of TL1A and DR3 in Autoimmune and Inflammatory Diseases | 2013 | 1 | 87 | 66% |
| The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation | 2013 | 1 | 43 | 58% |
| The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator | 2015 | 0 | 122 | 61% |
| Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease | 2014 | 3 | 168 | 23% |
| New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation | 2012 | 14 | 90 | 13% |
| Membrane Trafficking of Death Receptors: Implications on Signalling | 2013 | 5 | 148 | 16% |
| Molecular mechanism of TNF signaling and beyond | 2005 | 122 | 31 | 3% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HEADQUARTERS PBC NHOSLJ | 2 | 67% | 0.6% | 2 |
| 2 | INFLAMMATORY BOWEL IMMUNOBIOL | 1 | 13% | 1.9% | 6 |
| 3 | JOINT BIOMED | 1 | 33% | 0.6% | 2 |
| 4 | BEIJING PEDIAT OTOLARYNGOL HEAD NECK SC | 1 | 50% | 0.3% | 1 |
| 5 | BIORTP | 1 | 50% | 0.3% | 1 |
| 6 | CHEMOTHER Y RADIOTHER Y | 1 | 50% | 0.3% | 1 |
| 7 | CLIN EXCELLENCE MED GENET | 1 | 50% | 0.3% | 1 |
| 8 | MEDALEXANDRA HOSP | 1 | 50% | 0.3% | 1 |
| 9 | PROPAEDEUT INTERNAL MED 1GASTROENTEROL DI | 1 | 50% | 0.3% | 1 |
| 10 | SHEILA DAVID FUENTES PROGRAM CANC BIOL | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000144540 | LYMPHOTOXIN//LT BETA R//BTLA |
| 2 | 0.0000141369 | FN14//TWEAK//STWEAK |
| 3 | 0.0000116170 | PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR |
| 4 | 0.0000063803 | FAS//FAS LIGAND//AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
| 5 | 0.0000058915 | NOD2//CARD15//NOD1 |
| 6 | 0.0000058524 | 4 1BB//OX40//CD137 |
| 7 | 0.0000057844 | TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND |
| 8 | 0.0000049380 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
| 9 | 0.0000045721 | SHOCK TRAUMA S//SURG ALPERT MED//A549 CELL APOPTOSIS |
| 10 | 0.0000044783 | ENDOSIALIN//CD248//TEM1 |